trial · primary record
Zentalis
Advanced Pancreatic Adenocarcinoma
| Phase | Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 12 |
| Primary completion | 2026-05-23 |
| Primary endpoint | 6-month Progression-Free Survival (PFS) Rate |
| Registry ID | NCT06015659 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:56.137Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06015659
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.